drugset / Trial / NCT02782221

Lipolytic Effects of GH in Human Subjects in Vivo

NCT02782221

Completed 9 enrolled University of Aarhus
RandomizedCrossoverSingle-blindBasic science

Summary

Growth hormone (GH) induces fat metabolism. The mechanisms underlying the fat metabolizing effects of GH remain elusive. However, it is known that insulin suppresses fat metabolism, and GH inhibits the expression of certain insulin-dependent signaling proteins. We therefore hypothesize that the fat metabolizing effects of GH depend on abrogation of insulin-dependent signaling pathways. In order to investigate the fat metabolizing effects of GH, we'll analyze consecutive adipose tissue biopsies taken after GH exposure and GH blocking, respectively. Knowledge of the effects of growth hormone and fat metabolism can in shot-sight as well as in long-sight have great importance for the understanding of growth disorders from overweight and type 2 diabetes to malnutrition and eating disorders.

Timeline

Start
2016-05-30
Primary completion
2016-09-22
Completion
2017-01-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pegvisomant Protein / enzyme biologic 30 mg
Comparator Somatropin Protein / enzyme biologic 0.5 mg

Indications